Skip to main content

Table 1 Distribution of T-lymphocyte subsets (mean ± SE) in DLBCL patients at baseline and after three cycles of chemotherapy

From: Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy

Group

N

CD3+T cells (%)

CD3+CD4+T cells (%)

CD3+CD8+T cells (%)

Ratio of CD4+/CD8+

CD4+/CD25+T cells (%)

DLBCL patients at baseline

56

72.09 ± 3.16

32.31 ± 3.65

37.53 ± 6.46

0.85 ± 0.49

5.48 ± 4.96

DLBCL after three cycles of chemotherapy

56

71.24 ± 6.2

34.09 ± 4.63

32.51 ± 5.25

1.06 ± 0.87

8.32 ± 3.54

Healthy controls

26

72.90 ± 5.83

41.78 ± 4.23

28.51 ± 2.14

1.47 ± 0.27

3.68 ± 1.03